ACLX
Arcellx, Inc. · Healthcare · Biotechnology
Señales de momentum (gestores comparables): amplitud de titulares 0.0% · flujo de acciones +14.4% · nuevas posiciones netas 0.0% · fórmula
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q1 2025
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q1 2026 | 79 | -11 | 20.14M | $2.28B | +11 | −23 |
| Q4 2025 | 90 | +2 | 26.91M | $1.75B | +4 | −1 |
| Q3 2025 | 15 | -1 | 21.54M | $1.77B | n/a | −2 |
| Q2 2025 | 14 | -2 | 18.84M | $1.24B | n/a | −2 |
| Q1 2025 | 13 | 0 | 6.16M | $404.16M | +1 | −1 |
| Q4 2024 | 13 | +2 | 5.38M | $412.92M | +4 | −2 |
| Q3 2024 | 10 | +1 | 3.34M | $279.00M | +2 | −1 |
| Q2 2024 | 9 | n/a | 3.07M | $169.41M | n/a | n/a |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | T. Rowe Price ✦ | 1.84M | -13.3% | $120.68M | 0.0% | ▼ Trim | 4 | SEC ↗ ×2 |
| 2 | State Street Global Advisors ✦ (pasivo) | 1.67M | -6.1% | $109.32M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 3 | Geode Capital Management ✦ (pasivo) | 1.02M | +4.2% | $66.96M | 0.0% | ▲ Add | 4 | SEC ↗ ×2 |
| 4 | Citadel Advisors ✦ | 726.13K | +2778.5% | $47.63M | 0.0% | ▲ Add | 3 | SEC ↗ ×2 |
| 5 | Capital World Investors ✦ | 709.37K | +180.5% | $46.53M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 6 | Renaissance Technologies ✦ | 68.00K | +38.5% | $4.46M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 7 | Millennium Management ✦ | 51.06K | +128.2% | $3.35M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 8 | Wellington Management ✦ | 18.44K | -6.4% | $1.21M | 0.0% | ▼ Trim | 4 | SEC ↗ ×4 |
| 9 | AQR Capital Management ✦ | 17.14K | -15.3% | $1.12M | 0.0% | ▼ Trim | 4 | SEC ↗ ×5 |
| 10 | Marshall Wace ✦ | 15.40K | Nuevo | $1.01M | 0.0% | New | 1 | SEC ↗ |
| 11 | Norges Bank ✦ (pasivo) | 11.22K | -58.8% | $736,098 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 12 | Gotham Asset Management ✦ | 10.45K | -0.5% | $685,651 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 13 | Two Sigma Investments ✦ | 6.90K | 0.0% | $452,640 | 0.0% | Held | 4 | SEC ↗ |
"Their weight" = la participación de la posición en el valor de renta variable 13F reportado por ese manager: la medida de convicción. ✦ = manager curado.
Nuevos compradores
| Marshall Wace | $1.01M | 0.0% |
Posición cerrada
| Duquesne Family Office | $5.68M | era 0.2% |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 236 tenedores, 55.96M acciones, $5.94B declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué más suelen tener los titulares rastreados de este valor: recuentos de titularidad compartida, no relaciones fundamentales.